Clinical Trial

Usefulness of PET-CT for Invasive Fungal Infection

Study acronym: PETIFI
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this national multicenter prospective cohort study is to learn about the added value of 18F-FDG (18F-2-fluoro-2-deoxy-D-glucose) PET-CT in invasive fungal disease management. The main questions it aims to answer are: 1. Does the use of 18F-FDG PET-CT allow a better characterization of invasive fungal infection (IFI) (performance) compared to the exclusive use of conventional radiological studies in terms of extension/staging and monitoring of response/follow-up ? 2. Does the systematic and protocolized use of 18F-FDG PET-CT in IFI allow a better management of patients with IFI and increase the prognostic value of the initial evaluation? Participants will undergo systematically a 18F-FDG PET-CT as part of the work-up of their invasive fungal disease. Researchers will compare the performance of 18F-FDG PET-CT with standard management without 18F-FDG PET-CT to see if adds value (diagnostic, prognostic, and changes in management).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-01-15; most recent amendment 2024-11-04.
Status change: Not Yet Recruiting → Recruiting 2023-06-17
Trial Details
NCT Number NCT05688592
Lead Sponsor Puerta de Hierro University Hospital
Collaborators: Gilead Sciences
Conditions Invasive Fungal Infections
Enrollment 224 participants
Start Date 2023-04-27
Primary Completion 2024-10-31 (estimated)
Study Completion 2024-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-06